Future of maintenance therapy in multiple myeloma

Where is maintenance therapy heading?

Professor Meletios Dimopoulos, Professor Philippe Moreau and Dr Niels Van de Donk discuss the evidence currently available regarding the influence of maintenance therapy on patient outcomes in multiple myeloma and potential future treatment options.

The views expressed in this video are those of the speakers.

UK/NP/1806/0035am - August 2018

You are now leaving the Myeloma Hub

This link opens another website that is not under the review or control of Takeda UK Ltd and, as such, the company does not endorse the content, its accuracy, or any practices or standards contained within it. Please confirm you wish to continue.